Results 111 to 120 of about 12,212 (162)

Telmisartan-loaded liposomes: An innovative weapon against breast cancer

This study focuses on the development of a liposomal preparation for the targeted delivery of Telmisartan in the context of breast cancer treatment. Telmisartan, a pharmaceutical agent with potential anticancer properties, has been encapsulated within ...
Aditya Singh, Rani Kumari, Ravi Kumar, Shubhrat Maheshwari, Jagat Pal Yadav   +4 more
core   +1 more source

YK-4-250, a synthetic telmisartan-tempol conjugate: crystal structure of a stabilized free radical containing an angiotensin AT₁ receptor inhibitor. [PDF]

Acta Crystallogr C Struct Chem
Friedrich S, Kong Y, Musayev FN, Brown ML, Gupton BF.   +4 more
europepmc   +1 more source

Telmisartan Repurposing Targets Novel Biomarkers for Precision Colorectal Cancer Therapy. [PDF]

Pharmaceutics
Hunachagi S, Alqudihi HH, AbdulAzeez S, Borgio JF, Almohazey D.   +4 more
europepmc   +1 more source

Investigation of eletrochemical behaviours of telmisartan and determination of telmisartan in pharmaceutical formulation by voltametric methods

, 2008
Electrochemical behaviour of telmisartan, a drug to reduce blood pressurein highblood pressure patients, is examined and determination of telmisartan in pharma ceutical preparations is studied. Voltammetric analysis of telmisartan in two different buffer
Yıllmazğüç, Barış
core  

Effect of amlodipine and telmisartan on bone metabolism markers in newly diagnosed hypertensive patients. [PDF]

Bioinformation
Garg K, Raveendranath P, Gulati S, Zaheer S, Yadav A, Nandha R.   +5 more
europepmc   +1 more source

Telmisartan to prevent recurrent stroke and cardiovascular events.

, 2008
BACKGROUND: Prolonged lowering of blood pressure after a stroke reduces the risk of recurrent stroke. In addition, inhibition of the renin-angiotensin system in high-risk patients reduces the rate of subsequent cardiovascular events, including stroke ...
Gorelick, Philip, Albers, Gregory W, Toni, Danilo, Diener, Hans-Christoph, Lawton, William A, Yoon, Byung-Woo, Donnan, Geoffrey A, Cotton, Daniel, Bornstein, Natan, Yusuf, Salim, Cunha, Luis, Dahlöf, Björn, Bath, Philip, Estol, Conrado, Kaste, Markku, Chen, Sien-Tsong, Pais, Prem, Machnig, Thomas, Ounpuu, Stephanie, Voigt, Thor, Castaldo, John, Martin, Reneé H, VanderMaelen, Cam, Weber, Michael, Gu, Vivian, Chan, Bernard P L, Lu, Chuanzhen, Hilbrich, Lutz, Palesch, Yuko, Sacco, Ralph L, Teal, Philip, Skvortsova, Veronika, Hermansson, Karin, De Keyser, Jacques, Roberts, Robin   +34 more
core  

Strengthening access to antihypertensive medicines through HEARTS in the Americas: the Grenada experience. [PDF]

Rev Panam Salud Publica
Renaud-Thomas KA, Mark L, Isaac C, Malcolm T, Charles S.   +4 more
europepmc   +1 more source

Comparative bleeding risk between angiotensin II receptor blockers with high versus low P-glycoprotein inhibitory activity in patients with atrial fibrillation receiving direct oral anticoagulants. [PDF]

Hypertens Res
Kim S, You SC, Il Kim S, Bae JH, Choi JI, Park S.   +5 more
europepmc   +1 more source

Frequency and Profiles of Drug Combinations Constituting the Triple Whammy in Japan: An Analysis of a Patient Estimation Database. [PDF]

Pharmacy (Basel)
Maese M, Ito N, Shiokawa H, Kondo S, Okamoto Y, Iwata H, Urushibata S, Yamaura K.   +7 more
europepmc   +1 more source

Comparison of 3 Dual Single-Pill Combinations for Blood Pressure Lowering: A Secondary Analysis of an International Randomized Trial. [PDF]

Circulation
Schutte AE, Salam A, Cushman WC, de Silva HA, Di Tanna GL, Grobbee DE, Narkiewicz K, Ojji DB, Poulter NR, Schlaich MP, Spiering W, Williams B, Wright JT, Kumanan T, Hay P, Galappatthy G, Pereira T, Rahuman F, de Silva AP, Constantine G, Gianacas C, Vander Hoorn S, Shanthakumar M, Liu X, Wang N, Gnanenthiran SR, Whelton PK, Rodgers A, GMRx2 Investigators.   +28 more
europepmc   +1 more source